8-K: Body and Mind Inc. Announces Delay in Filing Annual Financial Statements

Body and Mind Inc. has announced a delay in filing its annual financial statements for the year ended July 31, 2024, due to additional audit procedures.

Summary

• Body and Mind Inc. (BaM) will not meet the November 28, 2024, deadline for filing its annual financial statements.
• The delay is due to additional financial procedures required by the auditors.
• These procedures include final approval of an external accounting memorandum, additional audit procedures, and final internal QC sign-off.
• The company is engaging an external accounting consultant to improve future filing processes.
• A management cease trade order has been issued against the CEO and CFO until the filings are complete.
• The company expects to file the 2024 Annual Financial Filings on or around December 9, 2024.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the filing delay, management cease trade order, and potential concerns about internal controls. The delay is a significant negative event for a public company.

Positives

• The company is taking steps to address the filing delay by engaging an external accounting consultant.
• The audit process is substantially complete, suggesting the delay is due to final procedures rather than fundamental issues.
• The company has applied for and received a management cease trade order, indicating compliance with regulatory requirements.

Negatives

• The company failed to meet the required filing deadline for its annual financial statements.
• A management cease trade order has been issued against the CEO and CFO, restricting their ability to trade company securities.
• The delay indicates potential weaknesses in the company's internal financial reporting processes.

Risks

• The delay in filing could negatively impact investor confidence.
• The management cease trade order could affect the company's ability to operate effectively.
• There is a risk that the additional audit procedures could uncover further issues.
• Failure to meet the revised filing deadline of December 9, 2024, could lead to further regulatory action.

Future Outlook

The company intends to file the 2024 Annual Financial Filings on or around December 9, 2024, and will provide information in accordance with National Policy 12-203 Management Cease Trade Orders until the filings are complete.

Management Comments

• The company has determined that it is not able to meet the November 28, 2024 filing deadline.
• The company is in the process of engaging an external accounting consultant to add to the company's resources in order to achieve future filing deadlines.

Industry Context

The cannabis industry is under increasing scrutiny regarding financial reporting, and delays can be viewed negatively by investors. This delay could raise concerns about the company's internal controls and financial management.

Comparison to Industry Standards

• Many cannabis companies face challenges in meeting reporting deadlines due to the complex regulatory environment and rapid growth.
• However, a delay of this nature is not typical for established public companies and may raise concerns about the company's financial controls.
• Companies like Canopy Growth and Aurora Cannabis have faced similar scrutiny regarding financial reporting, but they have generally met their filing deadlines, albeit sometimes with restatements.

Stakeholder Impact

• Shareholders may experience a negative impact on the stock price due to the filing delay.
• Employees may be concerned about the company's financial stability.
• Creditors may become more cautious about extending credit to the company.

Next Steps

• The company will file the 2024 Annual Financial Filings on or around December 9, 2024.
• The company will provide information in accordance with National Policy 12-203 Management Cease Trade Orders until the filings are complete.

Key Dates

Keywords

financial statements, audit, filing delay, management cease trade order, accounting, cannabis, BAMM, BMMJ